Skip to content
pramoxine
EntityQ1240076· pop 14· linked from 63 articles

Also known as p-butoxyphenyl gamma-morpholinopropyl ether, gamma-morpholinopropyl 4-n-butoxyphenyl ether, proxazocain, pramocaine

Pramocaine (INN and BAN, also known as pramoxine or pramoxine HCl) is a topical anesthetic discovered at Abbott Laboratories in 1953 and used as an antipruritic. During research and development, pramocaine hydrochloride stood out among a series of alkoxy aryl alkamine ethers as an especially good topical local anesthetic agent. Pharmacologic study revealed it to be potent and of low acute and subacute toxicity, well tolerated by most mucous membranes and of a low sensitizing index in humans. Like other local anesthetics, pramocaine decreases the permeability of neuronal membranes to sodium ion

Research

75 papers

via PubMed

~2 min read

Encyclopedic overview

4 sections
Contents
  • Use
  • Synthesis
  • See also
  • References

Pramocaine (INN and BAN, also known as pramoxine or pramoxine HCl) is a topical anesthetic discovered at Abbott Laboratories in 1953 and used as an antipruritic. During research and development, pramocaine hydrochloride stood out among a series of alkoxy aryl alkamine ethers as an especially good topical local anesthetic agent. Pharmacologic study revealed it to be potent and of low acute and subacute toxicity, well tolerated by most mucous membranes and of a low sensitizing index in humans. Like other local anesthetics, pramocaine decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses. Depolarization and repolarization of excitable neural membranes is thus inhibited, leading to numbness. Notably, pramocaine is chemically distinct from other local anesthetics, being neither an amino amide nor an amino ester.

== Use ==

Excerpted from Wikipedia’s “pramoxine” article, available under the CC BY-SA 4.0 licence.